Technology & Marketing Law Blog

JANUARY 9, 2024

Snap workaround of claiming to sue over Snap’s first-party product design choices, not the drug dealers’ content: Plaintiffs disavow any claim based upon Snap’s activities as a publisher of the third-party (drug seller) content. ”) as a defective product. As indicated by Doe II v.

Publishing 78

Publishing Designs Design Law 78

43(B)log

MARCH 25, 2024

Food & Drug Admin., In enacting the TCA, Congress found that “efforts to restrict advertising and marketing of tobacco products,” including existing mandatory warnings, had “failed adequately to curb tobacco use by adolescents, [so] comprehensive restrictions on the sale, promotion, and distribution of such products [were] needed.”

Advertising 64

Advertising Advertising Social Media Government 64

SpicyIP

JANUARY 2, 2022

This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). Top 10 Judgments/Orders [Topicality/Impact]. Hetero Drugs Ltd [Delhi High Court]. Hetero Drugs claimed that the drug was not being used in India and the export was only for research and development purposes.

IP 143

IP Intellectual Property Copyright Trademark 143

SpicyIP

FEBRUARY 5, 2024

Last week we published 9 posts on topics such as the Patent (2 nd Amendment) Rules, the Delhi High Court-Butter Chicken Controversy, and developments regarding the public search and e-register feature of the TMR website. Unfortunately, the issue of similar brand names for different drugs treating different ailments is pretty common in India.

Trademark 59

Trademark Settlement Licensing Copyright Infringement 59

SpicyIP

JULY 19, 2021

Topical Highlight. 195 of the Income Tax Act to deduct tax at source, as the distribution agreements/ EULAs in this case do not create any interest or right in such distributors/end-users, which would amount to the use of or right to use any copyright. News from India.

Advertising 105

Advertising Advertising Non-Fungible Tokens Intellectual Property 105

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Biosimilar Drug. In 2021, regulatory agencies focused on three interrelated issues: (1) decreasing anti-competitive behavior in the biosimilars space, (2) lowering biologic drug prices, and (3) providing further guidance to clarify the regulatory pathway for biosimilars. Tackling Biologic Drug Pricing. Reference Product.

Litigation 52

Litigation Settlement Patent Marketing 52

SpicyIP

JANUARY 27, 2024

For larger-than-law-type posts on this topic, check Prof. In sum, ‘tis a very interesting topic. National Pharmaceutical Policy(ies) and Pricing of Drugs – In 2011, this month, Shan Kohli discussed the Draft National Pharmaceuticals Policy which sought to establish a regulatory framework for drug pricing.

IP 64

IP Licensing Copyright Blogging 64

The IPKat

DECEMBER 5, 2021

While one could debate this topic from a non-legal standpoint (and perhaps we will return to it), one (unsolicited) question might be: What would have happened if Spotify had not agreed to remove the " shuffle " feature at Adele's request and she had decided to take her reasons to the legal level?

Moral Rights 143

Moral Rights Music Television Copyright 143